| Natural history and risk stratification in Andersen-Tawil syndrome type 1 A Mazzanti, D Guz, A Trancuccio, E Pagan, D Kukavica, T Chargeishvili, ... Journal of the American College of Cardiology 75 (15), 1772-1784, 2020 | 58 | 2020 |
| Tocilizumab in the treatment of COVID-19—A meta-analysis T Avni, L Leibovici, I Cohen, A Atamna, D Guz, M Paul, A Gafter-Gvili, ... QJM: An International Journal of Medicine 114 (8), 577-586, 2021 | 28 | 2021 |
| The yield of F18 FDG PET-CT for the investigation of fever of unknown origin, compared with diagnostic CT S Buchrits, A Gafter-Gvili, Y Eynath, H Bernstine, D Guz, T Avni European Journal of Internal Medicine 93, 50-56, 2021 | 19 | 2021 |
| β-Blockers, tachycardia, and survival following sepsis: an observational cohort study D Guz, S Buchritz, A Guz, A Ikan, T Babich, V Daitch, A Gafter-Gvili, ... Clinical Infectious Diseases 73 (4), e921-e926, 2021 | 11 | 2021 |
| Tocilizumab Treatment Effect on Iron Homeostasis in Severe COVID-19 Patients D Guz, A Gafter-Gvili, N Lev, G Sahaf Levin, S Lev Acta Haematologica 145 (4), 440-447, 2022 | 8 | 2022 |
| Clinical and pathological predictors for FDG-PET/CT avidity in patients with marginal zone lymphoma—a retrospective cohort study KBT Kagan, D Guz, S Buchrits, R Gurion, I Vaxman, M Priss, D Groshar, ... European Journal of Nuclear Medicine and Molecular Imaging 49 (7), 2290-2299, 2022 | 7 | 2022 |
| Ceftriaxone versus ampicillin for the treatment of community-acquired pneumonia. A propensity matched cohort study D Guz, M Bracha, Y Steinberg, D Kozlovsky, A Gafter-Gvili, T Avni Clinical Microbiology and Infection 29 (1), 70-76, 2023 | 4 | 2023 |
| Ceftriaxone 1 g versus 2 g per day, for the treatment of community-acquired pneumonia: a retrospective cohort study D Guz, R McNeil, S Buchrits, S Goshen, A Gafter-Gvili, T Avni Internal and Emergency Medicine 18 (7), 1919-1927, 2023 | 2 | 2023 |
| The contribution of 18F FDG PET-CT for the investigation of fever of unknown origin and inflammation of unknown origin-systematic review and meta-analysis S Buchrits, R McNeil, T Avni, D Fredman, D Guz, A Gafter-Gvili The American Journal of Medicine, 2024 | 1 | 2024 |
| Chloramphenicol versus ceftriaxone for the treatment of pneumonia and sepsis in elderly patients with advanced dementia and functional disability. A propensity-weighted … Y Eynath, R McNeil, S Buchrits, D Guz, D Fredman, A Gafter-Gvili, T Avni Journal of Antimicrobial Chemotherapy, dkae323, 2024 | | 2024 |
| Efficacy and Safety of Glofitamab in Patients with R/R DLBCL in Real Life Setting-a Retrospective Study R Gurion, D Guz, M Kedmi, C Perry, I Avivi Mazza, NA Horowitz, U Abadi, ... Blood 142 (Supplement 1), 5170-5170, 2023 | | 2023 |
| Novel insights on Andersen-Tawil syndrome type 1 A Mazzanti, D Guz, A Trancuccio, E Pagan, T Chargeishvili, EK Biernacka, ... European Heart Journal 41 (Supplement_2), ehaa946. 0744, 2020 | | 2020 |
| Clinical Characterization And Clinical Course Of Andersen Tawil Syndrome Patients D GUZ | | 2017 |
